P-RAPP Pilot Study and Your Patients (Procalcitonin (PCT) to Reduce Antibiotic use in Pediatric Pneumonia)
Your patients who present in the ED may be approached to participate in a pilot study to understand barriers of enrollment into a larger study that evaluates the use of low procalcitonin levels as a safe discriminator of bacterial infection. Most children with community acquired pneumonia (CAP) are unnecessarily treated with antibiotics. This pilot study would assess the barriers to enrollment into the larger study and hopefully overcome them. The next step would be a large multicenter trial to see if outpatient children with CAP and low PCT levels can be successfully treated without antibiotics.
Please Contact Dr. Richard Ruddy, Medical Director, Cincinnati Children's - Liberty Campus, with any questions.